Hepatitis C virus (HCV) infection is now considered a systemic disease due to the occurrence of extra-hepatic manifestations. Among these, the renal involvement is frequent. HCV infection, in fact, is strongly associated with proteinuria and chronic kidney disease (CKD) and negatively affects the prognosis of renal patients. In the last few...
-
2018 (v1)PublicationUploaded on: April 14, 2023
-
2014 (v1)Publication
Background: Triple therapy including Telaprevir or Boceprevir still represents in many European countries the standard of care for patients with Hepatitis C Virus genotype 1 infection. The number of patients who received this treatment resulted generally lower than expected. We investigated, among naïve patients, number and characteristics of...
Uploaded on: April 14, 2023 -
2018 (v1)Publication
Background & Aims: This study aimed to assess the real-life clinical and virological outcomes of HCV waitlisted patients for liver transplantation (LT) who received sofosbuvir/ribavirin (SOF/R) within the Italian compassionate use program. Methods: Clinical and virological data were collected in 224 patients with decompensated cirrhosis and/or...
Uploaded on: April 14, 2023 -
2017 (v1)Publication
Few data are available on the virological and clinical outcomes of advanced liver disease patients retreated after first-line DAA failure.
Uploaded on: April 14, 2023